Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalmefene for Craving in Behavioural Addictions
NCT05540288Phase 3Recruiting
- Sponsor
- CHU de Nantes
- Start
- Mar 2023
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nalmefene in gambling disorder (GD), Food addiction, compulsive sexual behavior disorder (CSBD), sponsored by CHU de Nantes. Started Mar 2023; status: recruiting.
02
Drugs
nalmefene
03
Conditions
gambling disorder (GD)Food addictioncompulsive sexual behavior disorder (CSBD)
Beyond the preview
Go deeper on NCT05540288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05540288.